Search Results - "Kitazono S"

518MO TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs).

Authors: Kitazono, S. Paz-Ares, L. Ahn, M-J. et al.

Source: Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1671-S1672. 2p.

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.

Authors: Zhou, C. Tang, K.-J. Cho, B. C. et al.

Source: New England Journal of Medicine. 11/30/2023, Vol. 389 Issue 22, p2039-2051. 13p.

1312P Datopotamab deruxtecan (Dato-DXd) vs docetaxel (DTX) in patients (pts) with advanced nonsquamous (NSQ) non-small cell lung cancer (NSCLC) with brain metastases (mets): Results from TROPION-Lung01.

Authors: Pons-Tostivint, E. Okamoto, I. Sands, J. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS835-S836. 2p.

552P TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in Asian patients (pts) with previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs).

Authors: Ahn, M-J. Cho, B.C. Goto, Y. et al.

Source: Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1684-S1685. 2p.

513MO Amivantamab plus chemotherapy vs chemotherapy as a first-line treatment among Asian patients with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer (NSCLC): PAPILLON subgroup analysis.

Authors: Zhou, C. Tang, K. Liu, B. et al.

Source: Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1668-S1669. 2p.

509MO Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01.

Authors: Ahn, M-J. Lisberg, A.E. Paz-Ares, L. et al.

Source: Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1665-S1666. 2p.

LBA12 Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01.

Authors: Ahn, M-J. Lisberg, A. Paz-Ares, L. et al.

Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS1305-S1306. 2p.

1314MO TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs).

Authors: Paz-Ares, L. Ahn, M-J. Lisberg, A.E. et al.

Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS755-S756. 2p.

Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study.

Authors: Kanda, S. Goto, K. Shiraishi, H. et al.

Source: Annals of Oncology. Dec2016, Vol. 27 Issue 12, p2242-2250. 9p. 1 Diagram, 3 Charts, 2 Graphs.

LBA5 Amivantamab plus chemotherapy vs chemotherapy as first-line treatment in EGFR Exon 20 insertion-mutated advanced non-small cell lung cancer (NSCLC): Primary results from PAPILLON, a randomized phase III global study.

Authors: Girard, N. Park, K. Tang, K. et al.

Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS1304-S1304. 1p.

A case treated with nivolumab after small cell lung cancer transformation of mutant EGFR non-small cell lung cancer.

Authors: Nishikawa, S. Tambo, Y. Ninomiya, H. et al.

Source: Annals of Oncology. Dec2016, Vol. 27 Issue 12, p2300-2302. 3p. 1 Diagram.

Amivantamab Plus Chemotherapy in Japanese Patients With EGFR Exon 20 Insertions NSCLC.

Authors: Kitazono S Ono A Kawamura T et al.

Source: Cancer science [Cancer Sci] 2025 Nov; Vol. 116 (11), pp. 3139-3148. Date of Electronic Publication: 2025 Sep 08.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE

Erratum: First-In-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non-Small-Cell Lung Cancer: TROPION-PanTumor01.

Authors: Shimizu T Sands J Yoh K et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Jun; Vol. 44 (16), pp. 1560. Date of Electronic Publication: 2026 Apr 30.

Publication Type: Journal Article; Published Erratum

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE; In Process

Amivantamab plus chemotherapy versus chemotherapy for first-line treatment of participants with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer: PAPILLON Asia subgroup analysis.

Authors: Zhou C Tang KJ Liu B et al.

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2026 Mar; Vol. 213, pp. 109302. Date of Electronic Publication: 2026 Feb 02.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Effect of Perioperative Inhaled Tiotropium for patients with chronic Obstructive Pulmonary disease in Esophageal cancer surgery (EPITOPE): an open-label, randomized, parallel-group pilot study.

Authors: Okamura A Watanabe M Miyazaki N et al.

Source: General thoracic and cardiovascular surgery [Gen Thorac Cardiovasc Surg] 2025 Jan; Vol. 73 (1), pp. 58-65. Date of Electronic Publication: 2024 Sep 18.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Springer Japan Country of Publication: Japan NLM ID: 101303952 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1863-6713 (Electronic) Linking ISSN: 18636705 NLM ISO Abbreviation: Gen Thorac Cardiovasc Surg Subsets: MEDLINE

High-cost treatments for advanced lung cancer in Japan (Lung Cancer Study Group of the Japan Clinical Oncology Group).

Authors: Watanabe K Sasaki K Machida R et al.

Source: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2024 Oct 03; Vol. 54 (10), pp. 1084-1092.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print Cited Medium: Internet ISSN: 1465-3621 (Electronic) Linking ISSN: 03682811 NLM ISO Abbreviation: Jpn J Clin Oncol Subsets: MEDLINE

First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.

Authors: Imai H Kijima T Azuma K et al.

Source: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2024 Apr 06; Vol. 54 (4), pp. 452-462.

Publication Type: Observational Study; Multicenter Study; Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print Cited Medium: Internet ISSN: 1465-3621 (Electronic) Linking ISSN: 03682811 NLM ISO Abbreviation: Jpn J Clin Oncol Subsets: MEDLINE

Soluble interleukin-2 receptor as a predictive biomarker for poor efficacy of combination treatment with anti-PD-1/PD-L1 antibodies and chemotherapy in non-small cell lung cancer patients.

Authors: Tozuka T Yanagitani N Yoshida H et al.

Source: Investigational new drugs [Invest New Drugs] 2023 Jun; Vol. 41 (3), pp. 411-420. Date of Electronic Publication: 2023 Apr 14.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

Pharmacokinetic and dose-finding study of osimertinib in patients with impaired renal function and low body weight.

Authors: Fujiwara Y Makihara R Hase T et al.

Source: Cancer science [Cancer Sci] 2023 May; Vol. 114 (5), pp. 2087-2097. Date of Electronic Publication: 2023 Feb 14.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study.

Authors: Ahn MJ Tanaka K Paz-Ares L et al.

Corporate Authors: Ahn MJ Tanaka K Paz-Ares L et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Jan 20; Vol. 43 (3), pp. 260-272. Date of Electronic Publication: 2024 Sep 09.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Comparative Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE